SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-28
👔
BRAINSTORM CELL THERAPEUTICS INC.
@BCLI_InsiderForm 4 Filing: Pitts Peter Joe Acquires (Grant) shares of $BCLI
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
BRAINSTORM CELL THERAPEUTICS INC.
Ticker: $BCLI
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-24
Shares: 900,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Pitts Peter Joe, holds the title of Executive Chairman at BRAINSTORM CELL THERAPEUTICS INC..
On 2026-07-24, the insider transacted 900,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Pitts Peter Joe (Executive Chairman) was granted $0 of $BCLI
Post-Transaction Position: 900,000 shares
SEC Accession No: 0001104659-26-087584 (CIK: 2138486)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.